Published in Z Gastroenterol on October 01, 1996
Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy. BMJ (1999) 2.28
Effectiveness of 4 pulpotomy techniques--randomized controlled trial. J Dent Res (2005) 1.90
Accuracy of electronic apex locators in comparison to actual length--an in vivo study. J Dent (2005) 1.60
Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis. Am J Gastroenterol (1997) 1.41
Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study. Eur J Gastroenterol Hepatol (1996) 1.40
[Megaloblastic anemia due to inadequate nutrition]. Dtsch Med Wochenschr (1997) 1.39
[Cyanosis and hourglass nails in chronic liver disease]. Internist (Berl) (1994) 1.39
Asymmetry of osmotic flow in frog intestine: functional and structural correlation. Am J Physiol (1970) 1.34
Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut (2005) 1.30
Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology (1992) 1.19
Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans. Eur J Endocrinol (2004) 1.16
Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology (1995) 1.14
European Cooperative Crohn's Disease Study (ECCDS): clinical features and natural history. Digestion (1985) 1.11
Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease--a randomized, placebo-controlled, double-blind cross-over trial. J Intern Med Suppl (1989) 1.07
Inter- and intra-observer variability of magnification chromoendoscopy for detecting specialized intestinal metaplasia at the gastroesophageal junction. Endoscopy (2004) 1.05
A 3' UTR transition within DEFB1 is associated with chronic and aggressive periodontitis. Genes Immun (2009) 1.03
Water movement across the cecal wall of the germfree rat. Proc Soc Exp Biol Med (1970) 1.03
Anti-inflammatory properties of unfractioned heparin in patients with highly active ulcerative colitis: a pilot study. Am J Gastroenterol (1997) 1.02
Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis. N Engl J Med (1988) 1.01
Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection. Eur J Gastroenterol Hepatol (1995) 0.96
Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease. Am J Gastroenterol (1999) 0.96
Goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives. Gastroenterology (1997) 0.95
Loperamide reduces the intestinal secretion but not the mucosal cAMP accumulation induced by choleratoxin. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.94
Gastrointestinal intramural hematoma, a complication of endoscopic injection methods for bleeding peptic ulcers: a case series. Endoscopy (1994) 0.93
Veno-occlusive disease of the liver in patients receiving immunosuppressive therapy. Virchows Arch A Pathol Anat Histol (1982) 0.91
Local epinephrine injection improves the therapeutic effect of Nd-YAG laser treatment of arterial peptic ulcer bleeding. Endoscopy (1988) 0.90
Discrepancy between effects of cholera toxin on net fluid movement and cAMP levels in rat jejunum, ileum, and colon. Dig Dis Sci (1988) 0.89
Ceftriaxone-associated nephrolithiasis. Ann Pharmacother (2000) 0.88
Influence of prophylactic local administration of epinephrine on bleeding complications after polypectomy. Endoscopy (1997) 0.88
Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease. Aliment Pharmacol Ther (2000) 0.88
Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. Gut (1997) 0.88
[Clofibrate in diabetes insipidus]. Klin Wochenschr (1971) 0.87
Detection of inflammatory bowel disease with 99mTc DTPA. Diagn Imaging (1980) 0.87
n-3 fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci (1996) 0.87
A prospective study of serum ghrelin levels in patients treated with clozapine. J Neural Transm (Vienna) (2005) 0.86
[Blue rubber-bleb nevus syndrome and therapeutic double balloon enteroscopy]. Z Gastroenterol (2006) 0.86
[Kinetic study of D-glucose reabsorption in the proximal convoluted tubule of rat kidney]. Pflugers Arch (1969) 0.86
Bactericidal effects of 2.94 microns Er:YAG-laser radiation in dental root canals. J Endod (1999) 0.86
Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide Study Group. Gut (1998) 0.86
Lower esophageal sphincter pressure in patients with gastroesophageal reflux diseases and posture and time patterns. Dis Esophagus (2004) 0.86
Inhibition by loperamide of deoxycholic acid induced intestinal secretion. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.85
Lipid treatment of inflammatory bowel disease. Curr Opin Clin Nutr Metab Care (1999) 0.85
[Clostridium difficile and antibiotic-associated colitis in risk patients: 2-month epidemiologic study in an intensive care unit]. Klin Wochenschr (1983) 0.84
[Differentiation of the active and passive components of D-glucose transport in the proximal tubule of rat kidney]. Pflugers Arch (1969) 0.84
Postprandial ghrelin release in anorectic patients before and after weight gain. Psychoneuroendocrinology (2005) 0.83
Antineutrophil and pancreatic autoantibodies in first-degree relatives of patients with inflammatory bowel disease. Scand J Gastroenterol (1998) 0.82
[Correlation of lymph node size and metastatic involvement of lymph nodes in bronchial cancer]. Langenbecks Arch Chir (1990) 0.82
Post-prandial decrease of human plasma ghrelin in the absence of insulin. J Endocrinol Invest (2003) 0.82
Age dependency of intrarenal resistance index (RI) in healthy adults and patients with fatty liver disease. Eur J Med Res (2007) 0.81
Rosacea fulminans in a patient with Crohn's disease: a case report and review of the literature. Acta Derm Venereol (2000) 0.81
Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors. J Nucl Med (1997) 0.80
The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease. Eur J Med Res (2005) 0.80
Regulation of ghrelin is related to estimated insulin sensitivity in obese children. Int J Obes (Lond) (2006) 0.80
Score card endoscopy: a multicenter study to evaluate learning curves in 1-week courses using the Erlangen Endo-Trainer. Endoscopy (2003) 0.79
Search for mumps virus genome in intestinal biopsy specimens of patients with IBD. Gastroenterology (1999) 0.79
K-ras mutations in sera of patients with colorectal neoplasias and long-standing inflammatory bowel disease. Scand J Gastroenterol (2002) 0.79
Nucleic acid and protein content of rat cecum mucosa in dietary adaptation-growth by cellular hyperplasia. Pflugers Arch (1977) 0.79
Intrarenal resistance index for the assessment of early renal function impairment in patients with liver cirrhosis. Eur J Med Res (2008) 0.79
Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C. Aliment Pharmacol Ther (2009) 0.79
Stimulation of sodium transport and Na+-K+-ATPase activity in the hypertrophying rat cecum. Pflugers Arch (1974) 0.78
[Alternative sonographic determination of liver size by intercostal scans]. Praxis (Bern 1994) (2006) 0.78
Passive sugar flux across frog jejunum in vitro. Pflugers Arch (1971) 0.78
Bacterial overgrowth in ileal reservoirs (Koch pouch): extended functional studies. Hepatogastroenterology (1980) 0.78
Induction of DNA synthesis by isoproterenol in the rat urinary bladder epithelium. Histochemistry (1974) 0.78
Sodium chloride transport of normal and dietary enlarged rat cecum in vitro. Digestion (1998) 0.78
Effectiveness of a novel endoscopy training concept. Endoscopy (2011) 0.78
Micropuncture experiments with saluretic sulfonamides. Ann N Y Acad Sci (1966) 0.78
p-ANCA target antigens in ulcerative colitis. Z Gastroenterol (1998) 0.78
Antinuclear autoantibodies in patients with inflammatory bowel disease. High prevalence in first-degree relatives. Dig Dis Sci (1997) 0.78
Adaptation of electrolyte transport in rat large intestine after proximal resection. I. Cecum and colon after 60% jejunoilectomy. Pflugers Arch (1986) 0.78
Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis. Neuropsychobiology (2000) 0.77
[Juxta-facet cysts: magnetic resonance tomography diagnosis]. Radiologe (2001) 0.77
Is the secretagogue effect of deoxycholic acid mediated by the adenylate cyclase-cAMP system. Digestion (1983) 0.77
[Interferon alpha-associated agranulocytosis during clozapine treatment. Case report and status of current knowledge]. Nervenarzt (2001) 0.77
Delta 32 mutation of the chemokine-receptor 5 gene in inflammatory bowel disease. Clin Immunol (2001) 0.77
Adaptation of electrolyte transport in rat large intestine after proximal resection. II. Colon after 50% jejunoilectomy combined with cecectomy. Pflugers Arch (1986) 0.77
The influence of bisacodyl and deacetylbisacodyl on mucus secretion, mucus synthesis and electrolyte movements in the rat colon in vivo. Eur J Pharmacol (1985) 0.77
Serum antibodies in first-degree relatives of patients with IBD: a marker of disease susceptibility? A follow-up pilot-study after 7 years. Digestion (2005) 0.77
Accuracy of 13C-urea breath test in clinical use for diagnosis of Helicobacter pylori infection. Z Gastroenterol (2000) 0.77
A score card for upper GI endoscopy: Evaluation of interobserver variability in examiners with various levels of experience. Z Gastroenterol (2002) 0.77
Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) I beta and IL-I receptor antagonist gene polymorphisms. Eur J Clin Invest (1998) 0.76
MICA*055: a new allele with eight GCT repeats in the exon 5 microsatellite. Tissue Antigens (2008) 0.76
Alpha1-antitrypsin alleles and phenotypes in patients with inflammatory bowel disease. Scand J Gastroenterol (1998) 0.76
[Therapy of Crohn diseases--results of a Consensus Conference of the German Society of Digestive and Metabolic Diseases]. Z Gastroenterol (1997) 0.76
Increased plasma concentration of surfactant protein D in chronic periodontitis independent of SFTPD genotype: potential role as a biomarker. Tissue Antigens (2008) 0.76
Endothelial cell autoantibodies are a marker of disease susceptibility in inflammatory bowel disease but apparently not linked to persistent measles virus infection. Clin Immunol (2000) 0.76
Low blood selenium concentration in Crohn disease. Ann Intern Med (1987) 0.76
Effects of a small bolus dose of ANF in healthy volunteers and in patients with volume retaining disorders. Klin Wochenschr (1990) 0.76
[A comparison of plain film, axial CT, 2D and 3D reconstructions in unstable spinal injuries following surgery]. Rofo (1993) 0.75
Improved ultrasound examination of pancreas grafts in type 1 (insulin-dependent) diabetic patients using tissue harmonic imaging. Transplant Proc (2003) 0.75
[Fatal drug-induced Lyell syndrome in combined benoxaprofen-aurothioglucose therapy]. MMW Munch Med Wochenschr (1982) 0.75
CMV encephalitis during ganciclovir therapy of CMV retinitis. Infection (1991) 0.75
Peptide YY release in anorectic patients after liquid meal. Appetite (2006) 0.75
[Solitary carcinoma metastasis in Paget's disease. Distinction from sarcomatous changes (author's transl)]. Arch Orthop Trauma Surg (1980) 0.75